Greg Pyszczymuka

Insider Reports History

Entity
Individual
Location
C/O Aytu Biopharma, Inc., 373 Inverness Parkway, Suite 206, Englewood, CO
Signature
/s/ Mark Oki as attorney-in-fact for Greg Pyszczymuka
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Greg Pyszczymuka:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AYTU BIOPHARMA, INC Chief Commercial Officer Common Shares 23.2K $43.3K $1.87 Sep 30, 2024 Direct
AYTU BIOPHARMA, INC Chief Commercial Officer Restricted Stock Units 417 $779 $1.87 Sep 30, 2024 Direct
AYTU BIOPHARMA, INC Chief Commercial Officer Employee Stock Option (Right to Buy) 7K Nov 6, 2024 Direct

Insider Reports Filed by Greg Pyszczymuka

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AYTU AYTU BIOPHARMA, INC Nov 6, 2024 1 $0 4 Nov 8, 2024 Chief Commercial Officer
AYTU AYTU BIOPHARMA, INC Sep 30, 2024 2 $0 4 Oct 2, 2024 Chief Commercial Officer
AYTU AYTU BIOPHARMA, INC Jun 30, 2024 2 $0 4 Jul 2, 2024 Chief Commercial Officer
AYTU AYTU BIOPHARMA, INC Mar 31, 2024 2 $0 4 Apr 2, 2024 Chief Commercial Officer
AYTU AYTU BIOPHARMA, INC Dec 31, 2023 2 $0 4 Jan 2, 2024 Chief Commercial Officer
AYTU AYTU BIOPHARMA, INC Sep 30, 2023 2 $0 4 Oct 3, 2023 Chief Commercial Officer
AYTU AYTU BIOPHARMA, INC Aug 11, 2023 1 $0 4 Aug 15, 2023 Chief Commercial Officer
AYTU AYTU BIOPHARMA, INC Jun 30, 2023 2 $0 4 Jul 6, 2023 Chief Commerical Officer
AYTU AYTU BIOPHARMA, INC Jun 16, 2023 1 $22.4K 4 Jun 20, 2023 Chief Commerical Officer
AYTU AYTU BIOPHARMA, INC Apr 25, 2023 2 $0 4 Jun 20, 2023 Chief Commerical Officer
AYTU AYTU BIOPHARMA, INC Dec 19, 2022 1 $24.5K 4 Dec 21, 2022 Chief Commercial Officer
AYTU AYTU BIOPHARMA, INC Nov 15, 2022 0 $0 3 Nov 15, 2022 Chief Commercial Officer